Abstract
Cardiovascular outcome trials of glucose‐lowering drugs in type 2 diabetes: 10 frequently asked questions
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have